Polyrizon Ltd.(PLRZ)Earnings, Financials & Key Ratios
PLRZ•NASDAQ
26.8× P/E·Price updated Jun 19, 2026
AboutPolyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.Show more
- Revenue$0
- EBITDA-$1M-87.6%
- Net Income-$2M-157.5%
- EPS (Diluted)0.50+412.5%
- ROE-57.83%+94.5%
PLRZ Key Insights
Polyrizon Ltd. (PLRZ) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 98 (top 2%)
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Shares diluted 47.3% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PLRZ posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PLRZ Price & Volume
Polyrizon Ltd. (PLRZ) stock price & volume — 10-year historical chart
Loading chart...
PLRZ Growth Metrics
Polyrizon Ltd. (PLRZ) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM39.74%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-20.86%
Return on Capital
10 Years-3107.04%
5 Years-3107.04%
3 Years-581.39%
Last Year-48.74%
PLRZ Peer Comparison
Polyrizon Ltd. (PLRZ) competitors in Drug Delivery Technology Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SIGA | 309.85M | 4.32 | 13.09 | -31.8% | 21.61% | 10.62% | 0.00 | |
 AGEN | 124.93M | 3.00 | -882.35 | 10.37% | 52.16% | |||
 NVAX | 1.5B | 9.13 | 3.59 | 64.69% | -14.73% | |||
 NRXP | 68.62M | 3.97 | -2.96 | -10.7% | ||||
 PRPH | 355.28K | 0.08 | -0.04 | -35.82% | -339.31% | -157.67% | 2.46 | |
 NNOX | 109.19M | 1.67 | -1.84 | 13.91% | -452.82% | -35.55% | 0.04 | |
 PFE | 143.46B | 25.22 | 18.54 | -1.65% | 11.83% | 8.34% | 0.78 | |
 MRK | 281.25B | 113.87 | 15.64 | 1.18% | 28.12% | 36.14% | 0.96 |
Compare PLRZ vs Peers
Polyrizon Ltd. (PLRZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PLRZ Income Statement
Polyrizon Ltd. (PLRZ) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - | - |
Cost of Goods Sold | 1K | 6K | 5K | 4K | 118K | 306K |
COGS % of Revenue | - | - | - | - | - | - |
Gross Profit | -1K▲ 0% | -6K▼ 500.0% | -5K▲ 16.7% | -4K▲ 20.0% | -118K▼ 2850.0% | -306K▲ 0% |
Gross Margin % | - | - | - | - | - | - |
Gross Profit Growth % | - | -500% | 16.67% | 20% | -2850% | - |
Operating Expenses | 71K | 697K | 895K | 635K | 1.3M | 835.04K |
OpEx % of Revenue | - | - | - | - | - | - |
Selling, General & Admin | 33K | 452K | 548K | 303K | 768K | 442.99K |
SG&A % of Revenue | - | - | - | - | - | - |
Research & Development | 38K | 245K | 347K | 332K | 534K | 397.98K |
R&D % of Revenue | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -5.92K |
Operating Income | -72K▲ 0% | -703K▼ 876.4% | -895K▼ 27.3% | -635K▲ 29.1% | -1.3M▼ 105.0% | 3.44K▲ 0% |
Operating Margin % | - | - | - | - | - | - |
Operating Income Growth % | - | -876.39% | -27.31% | 29.05% | -105.04% | - |
EBITDA | -71K | -697K | -890K | -631K | -1.18M | 120.69K |
EBITDA Margin % | - | - | - | - | - | - |
EBITDA Growth % | - | -881.69% | -27.69% | 29.1% | -87.64% | 109.87% |
D&A (Non-Cash Add-back) | 1K | 6K | 5K | 4K | 118K | 117.25K |
EBIT | -73K | -709K | -777K | -635K | -1.54M | -957.96K |
Net Interest Income | 0 | -2K | -2K | -230K | -28K | -3.04M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 100K |
Interest Expense | 0 | 2K | 2K | 2K | 3K | 3.14M |
Other Income/Expense | -1K | -8K | 116K | 35K | -243K | -4.57K |
Pretax Income | -73K▲ 0% | -711K▼ 874.0% | -779K▼ 9.6% | -600K▲ 23.0% | -1.54M▼ 157.5% | -1.14K▲ 0% |
Pretax Margin % | - | - | - | - | - | - |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -73K▲ 0% | -711K▼ 874.0% | -779K▼ 9.6% | -600K▲ 23.0% | -1.54M▼ 157.5% | -957.66K▲ 0% |
Net Margin % | - | - | - | - | - | - |
Net Income Growth % | - | -873.97% | -9.56% | 22.98% | -157.5% | 39.74% |
Net Income (Continuing) | -73K | -711K | -779K | -600K | -1.54M | -957.66K |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.02▲ 0% | -0.17▼ 877.0% | -0.20▼ 17.6% | -0.16▲ 20.0% | 0.50▲ 412.5% | -663.66▲ 0% |
EPS Growth % | - | -877.01% | -17.65% | 20% | 412.5% | -20.86% |
EPS (Basic) | -0.02 | -0.17 | -0.20 | -0.16 | 0.50 | - |
Diluted Shares Outstanding | 4.19M | 4.19M | 1.31M | 2.03M | 2.99M | 1.44K |
Basic Shares Outstanding | 4.19M | 4.19M | 1.31M | 2.03M | 2.99M | 1.44K |
Dividend Payout Ratio | - | - | - | - | - | - |
PLRZ Balance Sheet
Polyrizon Ltd. (PLRZ) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
Total Current Assets | 19K | 544K | 51K | 54K | 2.65M | 16.03M |
Cash & Short-Term Investments | 10K | 523K | 36K | 41K | 2.55M | 15.83M |
Cash Only | 10K | 523K | 36K | 4K | 2.55M | 15.83M |
Short-Term Investments | 0 | 0 | 0 | 37K | 0 | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - |
Other Current Assets | 9K | 21K | 15K | 13K | 99K | 204K |
Total Non-Current Assets | 5K | 143K | 495K | 505K | 2.89M | 2.71M |
Property, Plant & Equipment | 5K | 18K | 16K | 12K | 10K | 10K |
Fixed Asset Turnover | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 2.88M | 2.7M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 125K | 479K | 493K | 0 | 0 |
Total Assets | 24K▲ 0% | 687K▲ 2762.5% | 546K▼ 20.5% | 559K▲ 2.4% | 5.55M▲ 892.3% | 18.74M▲ 0% |
Asset Turnover | - | - | - | - | - | 0.00x |
Asset Growth % | - | 2762.5% | -20.52% | 2.38% | 892.31% | 7087.87% |
Total Current Liabilities | 8K | 690K | 1.2M | 502K | 261K | 364K |
Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 |
Days Payables Outstanding | - | - | - | - | - | - |
Short-Term Debt | 0 | 0 | 0 | 200K | 0 | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 672K | 1.16M | 263K | 45K | 319K |
Current Ratio | 2.38x | 0.79x | 0.04x | 0.11x | 10.16x | 44.04x |
Quick Ratio | 2.38x | 0.79x | 0.04x | 0.11x | 10.16x | 44.04x |
Cash Conversion Cycle | - | - | - | - | - | - |
Total Non-Current Liabilities | 0 | 0 | 0 | 248K | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 248K | 0 | 0 |
Total Liabilities | 8K | 690K | 1.2M | 750K | 261K | 364K |
Total Debt | 0 | 0 | 0 | 200K | 0 | 0 |
Net Debt | -10K | -523K | -36K | 196K | -2.55M | -15.83M |
Debt / Equity | - | - | - | 3.51x | - | 0.00x |
Debt / EBITDA | - | - | - | - | - | 0.00x |
Net Debt / EBITDA | - | - | - | - | - | -131.15x |
Interest Coverage | - | -351.50x | -447.50x | -317.50x | -434.00x | -0.30x |
Total Equity | 16K▲ 0% | -3K▼ 118.8% | -652K▼ 21633.3% | 57K▲ 108.7% | 5.29M▲ 9173.7% | 18.38M▲ 0% |
Equity Growth % | - | -118.75% | -21633.33% | 108.74% | 9173.68% | 25527.74% |
Book Value per Share | 0.00 | -0.00 | -0.50 | 0.03 | 1.77 | 12733.89 |
Total Shareholders' Equity | 16K | -3K | -652K | 57K | 5.29M | 18.38M |
Common Stock | 49K | 326K | 0 | 0 | 0 | 0 |
Retained Earnings | -1.43M | -2.14M | -2.92M | -3.52M | -5.07M | -5.24M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | -196K | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
PLRZ Cash Flow Statement
Polyrizon Ltd. (PLRZ) cash flow — operating, investing & free cash flow history
| Metric | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
Cash from Operations | -73K | -492K | -1.13M | -537K | -1.15M | -2.63M |
Operating CF Margin % | - | - | - | - | - | - |
Operating CF Growth % | - | -573.97% | -130.08% | 52.56% | -113.59% | -1181.7% |
Net Income | -73K | -711K | -779K | -600K | -1.54M | -957.66K |
Depreciation & Amortization | 1K | 6K | 5K | 4K | 118K | 117.25K |
Stock-Based Compensation | 0 | 184K | 130K | 100K | 51K | 8 |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 0 | 0 | -144K | -48K | 250K | -1.8M |
Working Capital Changes | -1K | 29K | -344K | 7K | -21K | 7.93K |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Investing | -6K | -19K | -3K | 0 | 29K | 27.02K |
Capital Expenditures | -6K | -19K | -3K | 0 | 0 | 0 |
CapEx % of Revenue | - | - | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | -1.98K |
Cash from Financing | 89K | 1.02M | 648K | 505K | 3.67M | 18.42M |
Debt Issued (Net) | 0 | 0 | 648K | 249K | -6K | -157K |
Equity Issued (Net) | 89K | 1000K | 648K | 256K | 1000K | 2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | 0 | -648K | 0 | 0 | 9.21K |
Net Change in Cash | 10K▲ 0% | 513K▲ 5030.0% | -487K▼ 194.9% | -32K▲ 93.4% | 2.55M▲ 8068.8% | 15.8M▲ 0% |
Free Cash Flow | -79K▲ 0% | -511K▼ 546.8% | -1.14M▼ 122.1% | -537K▲ 52.7% | -1.15M▼ 113.6% | -812.23K▲ 0% |
FCF Margin % | - | - | - | - | - | - |
FCF Growth % | - | -546.84% | -122.11% | 52.69% | -113.59% | 38.52% |
FCF per Share | -0.02 | -0.12 | -0.87 | -0.26 | -0.38 | -562.87 |
FCF Conversion (FCF/Net Income) | 1.00x | 0.69x | 1.45x | 0.90x | 0.74x | 0.85x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
PLRZ Key Ratios
Polyrizon Ltd. (PLRZ) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
Return on Equity (ROE) | -10938.46% | - | -1052.63% | -57.83% | -5.21% |
Return on Invested Capital (ROIC) | - | - | - | -65.43% | 0.1% |
Debt / Equity | - | - | 3.51x | - | 0.00x |
Interest Coverage | -351.50x | -447.50x | -317.50x | -434.00x | -0.30x |
FCF Conversion | 0.69x | 1.45x | 0.90x | 0.74x | 0.85x |
Related:PLRZ Dividend History·PLRZ Revenue History·PLRZ Price History·PLRZ P/E History·PLRZ Financial Ratios·PLRZ Institutional Holders
PLRZ Frequently Asked Questions
Polyrizon Ltd. (PLRZ) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Polyrizon Ltd. (PLRZ) grew revenue by 0.0% over the past year. Growth has been modest.
Polyrizon Ltd. (PLRZ) reported a net loss of $1.0M for fiscal year 2024.
Dividend & Returns
Polyrizon Ltd. (PLRZ) has a return on equity (ROE) of -57.8%. Negative ROE indicates the company is unprofitable.
Polyrizon Ltd. (PLRZ) had negative free cash flow of $0.8M in fiscal year 2024, likely due to heavy capital investments.